B855 (Repaglinide 2 mg)
Pill with imprint B855 is Red, Round and has been identified as Repaglinide 2 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 2 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for B855
Repaglinide
- Imprint:
- B855
- Strength:
- 2 mg
- Color:
- Red
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Meglitinides
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Breckenridge Pharmaceutical, Inc.
- National Drug Code (NDC):
- 51991-0855
More about repaglinide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 8 Reviews – Add your own review/rating
- Drug class: meglitinides
Consumer resources
Other brands: Prandin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
